Skip to main content
Earnings Labs
Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated (PRLD)

NASDAQ·Healthcare·Biotechnology

$3.99

+2.71%

Mkt Cap $196.21M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (6 analysts)

$8.00

Range $8.00 – $8.00

Implied Upside

+100.8%

Consensus $8.00 vs current $3.99